Self-Motivation
David Goggins
Former Navy Seal
Career Development
Bryan Cranston
Actor
Critical Thinking
Liv Boeree
International Poker Champion
Emotional Intelligence
Amaryllis Fox
Former CIA Clandestine Operative
Management
Chris Hadfield
Retired Canadian Astronaut & Author
Learn
from the world's big
thinkers
Start Learning

Michael Porter on Transforming Healthcare

Topic: The Future of Health Care

Michael Porter: Well I could probably say the most about healthcare because that’s an area where I devoted approximately the last five or six years really intensively to try and understand the puzzle of healthcare.

In healthcare, I think we have every opportunity to truly transform the value equation in healthcare if we actually are able to go back and step back from the incremental changes to what we have today, and ask ourselves what would it take for us to create a dramatically higher value system.

I’ve written a lot about this lately and talk about it incessantly now.

Things like, just how you organize care; things like, how you measure success. These things sound very, very simple, but our best guess is that we can get double the value from the amount of money we’re spending today. Or we can get pretty much the same value for half the money we’re spending. That’s the order of magnitude and transformation, and I’m very optimistic about healthcare because I now see enough grassroots, bottom-up effort, and enough belief in the basic framework of that value as how we need to think. And the patient perspective is what we should care about.

I can see a line in sight to a healthcare system that we’ll be proud of, and it will lead the world, and it will be affordable.

Recorded on: June 11, 2007

Michael Porter on why he's confident the U.S. can improve its healthcare system.

Live on Tuesday | Personal finance in the COVID-19 era

Sallie Krawcheck and Bob Kulhan will be talking money, jobs, and how the pandemic will disproportionally affect women's finances.

How often do vaccine trials hit paydirt?

Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.

Pedro Vilela/Getty Images
Surprising Science

Vaccines are more likely to get through clinical trials than any other type of drug — but have been given relatively little pharmaceutical industry support during the last two decades, according to a new study by MIT scholars.

Keep reading Show less

Consumer advocacy groups are mostly funded by Big Pharma, according to new research

An article in Journal of Bioethical Inquiry raises questions about the goal of these advocacy groups.

Image by Jukka Niittymaa / Pixabay
Politics & Current Affairs
  • Two-thirds of American consumer advocacy groups are funded by pharmaceutical companies.
  • The authors of an article in Journal of Bioethical Inquiry say this compromises their advocacy.
  • Groups like the National Alliance on Mental Illness act more like lobbyists than patient advocates.

Keep reading Show less

Bubonic plague case reported in China

Health officials in China reported that a man was infected with bubonic plague, the infectious disease that caused the Black Death.

(Photo by Centers for Disease Control and Prevention/Getty Images)
Coronavirus
  • The case was reported in the city of Bayannur, which has issued a level-three plague prevention warning.
  • Modern antibiotics can effectively treat bubonic plague, which spreads mainly by fleas.
  • Chinese health officials are also monitoring a newly discovered type of swine flu that has the potential to develop into a pandemic virus.
Keep reading Show less

Women who go to church have more kids—and more help

Want help raising your kids? Spend more time at church, says new study.

Pixabay
Culture & Religion
  • Religious people tend to have more children than secular people, but why remains unknown.
  • A new study suggests that the social circles provided by regular church going make raising kids easier.
  • Conversely, having a large secular social group made women less likely to have children.
Keep reading Show less
Quantcast